Small Molecules Blog


Somatic Instability and Huntington's Disease


Development of a KRAS-Targeting PROTAC

Development of a KRAS Targeting PROTAC Banner

 

In this question-and-answer session, Michael Bond (Yale University) talks to our Senior Product Specialist, Alex Moloney PhD, about the development of a KRAS G12C-targeting PROTAC® which is now available from Tocris.


Regenerative Medicine - From Bench to Clinic


SARS-CoV-2: An Update on Key Targets, Trends and Discoveries


Existing Drugs Targeting SARS-CoV-2 and Coronaviruses

Existing Drugs Targeting SARS-CoV-2 and Coronaviruses

All Tocris products mentioned in this blog post are for biomedical research use only. They are not intended for human or veterinary use.


ROCK Inhibitor for Stem Cell Cryopreservation


Celebrating 25 Years of Tocris Cookson


Targeting the Immune System in Cancer with Small Molecules


Five Reasons to use Small Molecules in Stem Cell Research